A Case of Posterior Reversible Encephalopathy Syndrome Associated with Gilenya(®) (Fingolimod) Treatment for Multiple Sclerosis

We describe posterior reversible encephalopathy syndrome (PRES) in a woman with multiple sclerosis treated with Gilenya(®) (Fingolimod). The first symptoms appeared after 21 months of fingolimod treatment. She experienced headache, altered mental status, cognitive deficits, seizures, and visual dist...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindå, Hans, von Heijne, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349179/
https://www.ncbi.nlm.nih.gov/pubmed/25788891
http://dx.doi.org/10.3389/fneur.2015.00039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349179/
https://www.ncbi.nlm.nih.gov/pubmed/25788891
http://dx.doi.org/10.3389/fneur.2015.00039

Ejemplares similares